• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管质量倡议中,与常见年龄接受血运重建的患者相比,外周动脉疾病患者的主要肢体不良事件。

Major Adverse Limb Events Among Patients with Premature Peripheral Artery Disease Compared with Those at the Common Age Undergoing Revascularization in the Vascular Quality Initiative.

机构信息

Division of Vascular Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT.

Yale School of Public Health, New Haven, CT.

出版信息

Ann Vasc Surg. 2022 Nov;87:188-197. doi: 10.1016/j.avsg.2022.07.007. Epub 2022 Aug 2.

DOI:10.1016/j.avsg.2022.07.007
PMID:35926786
Abstract

BACKGROUND

Premature peripheral artery disease (PAD), defined as ≤ 50 years of age, is associated with poor outcomes following lower extremity revascularization (LER). However, the specific characteristics and outcomes of this group of patients compared to those at the common age undergoing revascularization have not been examined. The aim of this study is to compare patients with early versus late onset premature PAD undergoing LER focusing on major adverse limb events (MALEs).

METHODS

All LER procedures (open and endovascular) in the Vascular Quality Initiative (VQI) were reviewed. A histogram of patient age at the time of initial LER (no prior LER) was used to define the common age, which included all patients within one standard deviation of the mean. Characteristics and outcomes of patients with premature PAD were compared to patients treated at the common age of presentation undergoing LER.

RESULTS

A histogram of all patients undergoing LER was used to define 60 to 80 years as the common age. Patients with premature PAD were more likely to be female, African American, and Hispanic compared to patients at the common age. Patients with premature PAD were also more likely to have insulin-dependent diabetes, be current smokers, on dialysis, and be treated for claudication. Patients with premature PAD were less likely to have Transatlantic Intersociety Consensus (TASC II) C or D disease and were less likely to be on antiplatelets and statins. These differences were more pronounced in patients with chronic limb-threatening ischemia (CLTI). Cox proportional hazards regression demonstrated that premature PAD was independently associated with major adverse limb events (MALEs) at 1-year for patients with claudication (HR:1.7, 95% CI:1.4-2.0) and CLTI (HR:1.3, 95% CI:1.2-1.5) compared to patients 60 to 80 years of age.

CONCLUSIONS

Patients with premature PAD have significant differences in characteristics compared to patients treated at the common age. Vascular providers should emphasize medical therapy prior to LER given the lower rates of medical optimization and worse 1-year MALEs in patients with premature PAD.

摘要

背景

定义为≤50 岁的早期外周动脉疾病(PAD)与下肢血运重建(LER)后的不良预后相关。然而,与接受血运重建的常见年龄患者相比,该组患者的具体特征和结局尚未得到检查。本研究的目的是比较早发性和晚发性早发性 PAD 患者接受 LER 的情况,重点是主要不良肢体事件(MALEs)。

方法

回顾了血管质量倡议(VQI)中的所有 LER 手术(开放和血管内)。初始 LER(无先前 LER)时患者年龄的直方图用于定义常见年龄,包括平均值一个标准差内的所有患者。将早发性 PAD 患者的特征和结局与在常见年龄接受 LER 治疗的患者进行比较。

结果

使用所有接受 LER 治疗的患者的直方图来定义 60 至 80 岁为常见年龄。与常见年龄的患者相比,早发性 PAD 患者更可能是女性、非裔美国人和西班牙裔。早发性 PAD 患者也更可能患有胰岛素依赖型糖尿病、目前吸烟、接受透析治疗和接受跛行治疗。早发性 PAD 患者 TASC II C 或 D 疾病的发生率较低,抗血小板药物和他汀类药物的使用率也较低。在慢性肢体威胁性缺血(CLTI)患者中,这些差异更为明显。Cox 比例风险回归表明,对于跛行患者(HR:1.7,95%CI:1.4-2.0)和 CLTI 患者(HR:1.3,95%CI:1.2-1.5),早发性 PAD 与 1 年时的主要不良肢体事件(MALEs)独立相关与 60 至 80 岁的患者相比。

结论

与接受常见年龄治疗的患者相比,早发性 PAD 患者的特征存在显著差异。鉴于早发性 PAD 患者的医疗优化率较低且 1 年 MALEs 较差,血管提供者应在 LER 前强调药物治疗。

相似文献

1
Major Adverse Limb Events Among Patients with Premature Peripheral Artery Disease Compared with Those at the Common Age Undergoing Revascularization in the Vascular Quality Initiative.血管质量倡议中,与常见年龄接受血运重建的患者相比,外周动脉疾病患者的主要肢体不良事件。
Ann Vasc Surg. 2022 Nov;87:188-197. doi: 10.1016/j.avsg.2022.07.007. Epub 2022 Aug 2.
2
Lower Extremity Revascularization for Chronic Limb-Threatening Ischemia among Patients at the Extremes of Age.高龄患者下肢慢性肢体威胁性缺血的血运重建。
Ann Vasc Surg. 2021 Apr;72:517-528. doi: 10.1016/j.avsg.2020.08.135. Epub 2020 Sep 12.
3
Reinterventions in Patients with Claudication and Chronic Limb Threatening Ischemia.间歇性跛行和慢性肢体威胁性缺血患者的再次干预
Ann Vasc Surg. 2022 Feb;79:56-64. doi: 10.1016/j.avsg.2021.07.050. Epub 2021 Oct 14.
4
Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization.下肢血运重建术治疗的早发性外周动脉疾病患者的抗凝治疗。
Ann Vasc Surg. 2024 Aug;105:150-157. doi: 10.1016/j.avsg.2024.02.006. Epub 2024 Apr 7.
5
Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.有或无既往血运重建的患者行股腘动脉旁路移植术的围手术期结局
J Vasc Surg. 2017 May;65(5):1354-1365.e2. doi: 10.1016/j.jvs.2016.10.114. Epub 2017 Feb 9.
6
Association between sex and long-term outcomes of endovascular treatment for peripheral artery disease.性别与外周动脉疾病血管内治疗长期预后之间的关联
Catheter Cardiovasc Interv. 2023 Apr;101(5):877-887. doi: 10.1002/ccd.30617. Epub 2023 Mar 15.
7
Rates of Intervention for Claudication versus Chronic Limb-Threatening Ischemia in Canada and United States.加拿大和美国的间歇性跛行与慢性肢体威胁性缺血的干预率。
Ann Vasc Surg. 2022 May;82:131-143. doi: 10.1016/j.avsg.2021.10.068. Epub 2021 Dec 10.
8
Multiple Reinterventions for Claudication are Associated with Progression to Chronic Limb-Threatening Ischemia.对于间歇性跛行的多次再介入与进展为慢性肢体威胁性缺血相关。
Ann Vasc Surg. 2021 Apr;72:166-174. doi: 10.1016/j.avsg.2020.10.004. Epub 2020 Nov 21.
9
Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery disease.伴有早发周围动脉疾病的患者中,晚期股腘动脉病变的旁路和血管内介入治疗的结果。
J Vasc Surg. 2021 Dec;74(6):1968-1977.e3. doi: 10.1016/j.jvs.2021.05.034. Epub 2021 Jun 6.
10
Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.下肢动脉疾病初次血运重建策略中旁路和血管内介入治疗的患者选择和围手术期结局。
J Vasc Surg. 2018 Jan;67(1):206-216.e2. doi: 10.1016/j.jvs.2017.05.132. Epub 2017 Aug 24.

引用本文的文献

1
Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI.慢性肢体威胁性缺血血管重建术后的年龄相关结局:BEST-CLI分析
Circ Cardiovasc Interv. 2025 Jun;18(6):e014833. doi: 10.1161/CIRCINTERVENTIONS.124.014833. Epub 2025 Apr 3.
2
Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series.介入心脏病学中的时间年龄与生物年龄:为老年患者提供全面关怀的综合方法:JACC 家族系列。
JACC Cardiovasc Interv. 2024 Apr 22;17(8):961-978. doi: 10.1016/j.jcin.2024.01.284. Epub 2024 Apr 8.
3
Systematic review and meta-analysis of the genetics of peripheral arterial disease.
外周动脉疾病遗传学的系统评价与荟萃分析。
JVS Vasc Sci. 2023 Nov 14;5:100133. doi: 10.1016/j.jvssci.2023.100133. eCollection 2024.